29 results
DEFM14A
APGN
Apexigen Inc
30 Jun 23
Proxy related to merger
4:21pm
have significantly greater financial, manufacturing, marketing, drug development, technical and human resources, and commercial expertise than Apexigen … , manufacturing, commercial, drug development and technical expertise and human resources than Apexigen. Large pharmaceutical and biotechnology companies
424B3
APGN
Apexigen Inc
10 Apr 23
Prospectus supplement
4:03pm
financial, manufacturing, marketing, drug development, technical and human resources, and commercial expertise than we do. Large pharmaceutical … of salaries, benefits, and stock-based compensation expense for personnel in executive, operations, legal, human resources, finance and administrative
424B3
APGN
Apexigen Inc
10 Apr 23
Prospectus supplement
4:02pm
, operations, legal, human resources, finance and administrative functions, professional fees for legal, patent, consulting, accounting and audit services … , manufacturing, commercial, drug development and technical expertise and human resources than we do. Large pharmaceutical and biotechnology companies
POS AM
k6nf5jfw 1elszky3w
4 Apr 23
Prospectus update (post-effective amendment)
4:24pm
POS AM
ta43omd0y84
4 Apr 23
Prospectus update (post-effective amendment)
4:23pm
424B3
k3mi6sh6 td3idpgbs
9 Sep 22
Prospectus supplement
4:40pm
424B3
pj5qdomn9kiy
9 Sep 22
Prospectus supplement
4:38pm
8-K/A
EX-99.2
ty0e3p09 tba
18 Aug 22
Index to Unaudited Condensed Financial Statements
4:48pm
8-K
EX-10.5
xfw oevkes7ln
4 Aug 22
Entry into a Material Definitive Agreement
4:32pm
8-K
EX-10.6
nwifvdtfzfko9t6
4 Aug 22
Entry into a Material Definitive Agreement
4:32pm
424B3
rly0 ecnx
6 Jul 22
Prospectus supplement
4:18pm